About Brian Eisner, MD

Dr. Brian Eisner is the Co-Director of the Kidney Stone Program at the MGH. He specializes in kidney stone surgery, kidney stone prevention, endourology and related research.

He serves as the Medical Director of the Massachusetts General Hospital Department of Urology and the Chief of the Division of Urology at Newton Wellesley Hospital.

Dr. Eisner was born in Miami, FL and attended Harvard College and the University of Michigan Medical School. He completed urology residency training at Massachusetts General Hospital and a fellowship in endourology and urinary stone disease at the University of California, San Francisco. His clinical practice focuses on kidney stone prevention, minimally invasive and surgical treatments for kidney stones, and endourology. He is actively involved in research involving kidney stone prevention, risk factors for kidney stone disease and surgical treatment of kidney stones.

 

Departments, Centers, & Programs:

Clinical Interests:

Treats:

Locations

Mass General Urology
165 Cambridge St.
7th Floor
Boston, MA 02114
Phone: 857-238-3838

Medical Education

  • MD, University of Michigan Medical School
  • Fellowship, Massachusetts General Hospital
  • Fellowship, University of California, San Francisco

American Board Certifications

  • Urology, American Board of Urology

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

Dr. Eisner's research interests include prevention of kidney stone disease, risk factors for kidney stone disease, surgical treatment for kidney stones, endourology, and radiology of the urinary tract.

Publications

  • Select Publications:

    • Eisner BH, Asplin JA, Goldfarb DS, Ahmad A, Stoller ML. Citrate, malate, and alkali concentrations in commonly consumed diet sodas: implications for nephrolithiasis treatment. J Urol (in press)
    • Eisner BH, Porten SP, Bechis SK, Stoller ML. Diabetic kidney stone-formers excrete more oxalate and have lower urine pH than non-diabetic stone formers. J Urol (in press)
    • Eisner BH, Porten SP, Bechis SK, Stoller ML. The Role of Race in Determining 24-Hour Urine Composition in White and Asian/Pacific Islander Stone Formers. J Urol. 2010;183(4):1407-1411.
    • Eisner BH, Porten SP, Bechis SK, Stoller ML. Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasis. J Urol. 2010;183(2):576-9.
    • Chi T, Eisner BH, Berger AD, Stoller ML. An ex-vivo evaluation of the application and strength of a novel laparoscopic knot substitute device. J Endourol. 2010;24(1):95-8.
    • Eisner BH, Eisenberg ML, Stoller ML. Relationship Between Body Mass Index and Quantitative 24-Hour Urine Chemistries in Patients With Nephrolithiasis. Urology. 2009.

Reviews: Comments and Ratings